Sign in

    Johnathan McCary

    Senior Equity Research Associate at Raymond James

    Johnathan McCary is a Senior Equity Research Associate at Raymond James, specializing in Application Software with primary coverage of companies such as Salesforce (CRM), HubSpot (HUBS), and Veeva Systems (VEEV). He began his role at Raymond James in June 2022, after serving as a Corporate Development Associate at SafeRx Pharmaceuticals and managing a $1 million portfolio with the Gator Student Investment Fund, where he also trained analysts in value investing. McCary holds a Master of Science in Finance from the University of Florida and is FINRA-registered, with practical experience gained through internships at both Raymond James and Comcast NBCUniversal before joining full-time. His recent performance includes active research involvement and a record of supporting investment decisions in the dynamic software sector.

    Johnathan McCary's questions to Definitive Healthcare (DH) leadership

    Johnathan McCary's questions to Definitive Healthcare (DH) leadership • Q2 2025

    Question

    Johnathan McCary of Raymond James asked if 'boomerang' customers are becoming a broader trend and inquired about any changes in the competitive landscape or the types of competitors Definitive Healthcare is displacing.

    Answer

    CEO Kevin Coop stated the competitive environment is largely unchanged, facing integrated software platforms at the high end and point solutions competing on price at the low end. He emphasized that Definitive Healthcare competes on data quality and service, noting that boomerang customers often return after experiencing the lower value of cheaper alternatives.

    Ask Fintool Equity Research AI

    Johnathan McCary's questions to Definitive Healthcare (DH) leadership • Q2 2025

    Question

    Johnathan McCary of Raymond James inquired if 'boomerang customers' returning to the platform is becoming a broader trend and asked for an update on the competitive environment.

    Answer

    CEO Kevin Coop stated that the competitive landscape has not materially changed. He explained that Definitive Healthcare competes with high-end platforms on the basis of its differentiated, higher-quality data and with low-end point solutions on service and value, not price. He confirmed that 'boomerang' customers often return after finding lower-priced alternatives lack the necessary data quality and accuracy.

    Ask Fintool Equity Research AI

    Johnathan McCary's questions to OneStream (OS) leadership

    Johnathan McCary's questions to OneStream (OS) leadership • Q2 2025

    Question

    Johnathan McCary, on for Brian Peterson, asked about the impact of foreign exchange rates on revenue and billings and what FX assumptions are included in the guidance.

    Answer

    CFO Bill Koefoed explained that the strong dollar in late 2024 created a headwind for 2025 revenue recognition. He noted that the dollar has weakened recently. If current, more favorable rates hold through Q4, it would create a tailwind for revenue recognized in fiscal 2026 from billings made at the end of 2025.

    Ask Fintool Equity Research AI

    Johnathan McCary's questions to Paylocity Holding (PCTY) leadership

    Johnathan McCary's questions to Paylocity Holding (PCTY) leadership • Q4 2025

    Question

    Johnathan McCary of Raymond James inquired about the company's appetite for M&A now that the initial Airbase integration is underway and whether there are new strategic product areas of interest.

    Answer

    President, CEO & Director Toby Williams stated that the company's M&A strategy remains consistent: to be open to acquisitions that accelerate the product roadmap. He emphasized a high bar for any potential deal, requiring tight integration to ensure an acquired product feels native to the Paylocity platform.

    Ask Fintool Equity Research AI

    Johnathan McCary's questions to Intapp (INTA) leadership

    Johnathan McCary's questions to Intapp (INTA) leadership • Q3 2025

    Question

    Johnathan McCary from Raymond James asked about the demand generation impact from the Intapp Amplify product event, seeking quantification of pipeline build or customer re-engagement beyond the number of attendees.

    Answer

    John Hall, Chairman and CEO, described the event as a success with tremendous turnout and enthusiasm for new products, particularly the AI-driven Intapp Assist origination capability and the next-generation Intapp Time. He confirmed a strong pipeline response and noted there was a 'line out the door' for demos, indicating significant client engagement.

    Ask Fintool Equity Research AI

    Johnathan McCary's questions to Waystar Holding (WAY) leadership

    Johnathan McCary's questions to Waystar Holding (WAY) leadership • Q4 2024

    Question

    Johnathan McCary asked if traction with larger, more complex health systems has increased and if deals over $100,000 are becoming a larger portion of the pipeline.

    Answer

    CEO Matt Hawkins confirmed strong momentum with both large health systems and ambulatory clients, stating that the pipeline entering 2025 is stronger than it was at the start of 2024. While not providing specific pipeline composition details, he noted that strong client satisfaction scores and a library of case studies are effectively supporting go-to-market efforts across all segments.

    Ask Fintool Equity Research AI